Detalles de la búsqueda
1.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol
; 202(4): 749-759, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36257914
2.
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study.
J Clin Oncol
; 41(3): 555-567, 2023 01 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35658525
3.
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England.
J Med Econ
; 25(1): 730-740, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35611697
Resultados
1 -
3
de 3
1
Próxima >
>>